, is recommended as the ﬁrst choice wherever
possible, mainly because it is the less invasive option
and has good results. Although PTA is a common treatment for in-stent restenosis, recurrent restenosis seems
to limit the durability, leading to recurrent interventions
and associated cost implications.472 An analysis of the
VQI database showed no signiﬁcant differences in 1year stroke, death, and stroke/death between primary
CAS and redo